ApoGen Biotechnologies
Latest round
- Series A
Last raised
- Dec 2016
Total raised
- $7M
Investors
- 9
About ApoGen Biotechnologies
ApoGen Biotechnologies, Inc.Founded in 2014, ApoGen Biotechnologies, Inc. is headquartered in Seattle, US. The company specializes in overcoming drug resistance in cancer therapies.ApoGen Biotechnologies, Inc. specializes in developing innovative therapies aimed at overcoming drug resistance in cancer treatment. The company’s core product offerings focus on targeting the key drivers of ongoing DNA mutation and tumor evolution, thus presenting a new class of therapies designed to enhance the efficacy of existing cancer treatments. By leveraging advanced biotechnological approaches, ApoGen seeks to address critical challenges faced by oncologists and patients alike, particularly in the realm of personalized medicine. Their solutions are intended for healthcare providers, including hospitals and specialized oncology clinics, that serve patients diagnosed with resistant forms of cancer.ApoGen Biotechnologies generates revenue through strategic partnerships and collaborations with healthcare providers and research institutions, focusing on the commercialization of their groundbreaking therapies. Transactions typically occur through B2B agreements, where healthcare institutions may engage in licensing arrangements or collaborative research initiatives. The company’s business model emphasizes long-term partnerships to facilitate the integration of its therapies into clinical practices, thereby enhancing patient care. The company intends to expand its market presence in North America and Europe by launching new products that target ongoing DNA mutations and tumor evolution.
Who invested in ApoGen Biotechnologies
9 investors across 1 round
See all investors in ApoGen Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 12, 2016
Amount
$7M
Investors
Questions about ApoGen Biotechnologies
Who invested in ApoGen Biotechnologies?
ApoGen Biotechnologies has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ApoGen Biotechnologies raised?
ApoGen Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ApoGen Biotechnologies last raise money?
ApoGen Biotechnologies's most recent round on record is a Series A, in Dec 2016.
What does ApoGen Biotechnologies do?
ApoGen Biotechnologies is a pharmaceuticals company.
Where is ApoGen Biotechnologies headquartered?
ApoGen Biotechnologies is headquartered in Seattle, US.
Which VCs invest in companies like ApoGen Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at ApoGen Biotechnologies's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like ApoGen Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.